Echo Therapeutics
Philadelphia · Founded 1989
About Echo Therapeutics
Echo Therapeutics is a medical device company with deep expertise in advanced skin permeation technology. Echo is developing its Symphony® CGM System as a non-invasive, wireless, continuous glucose monitoring system for use in hospital critical care units and for people with diabetes. The Prelude® SkinPrep System, a component of their Symphony CGM System, allows for enhanced skin permeation that will enable extraction of analytes, such as glucose, and transdermal drug delivery.
Company Facts
- Founded: 1989
- Legal name: Echo Therapeutics Inc.
- Operating status: IPO
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $44.7M
- Funding stage: IPO
- Last round: Post-IPO Debt (Feb 2016)
- Website: echotx.com
- Phone: (215) 717-4100
Social Profiles
Canonical: https://fsome.com/organization/echo-therapeutics-8392383 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.